REPLIGEN CORP acquired Engineered Molding Technology LLC (EMT) for NULL (part of $175.0M combined cash used for EMT, NMS and ARTeSYN in 2020), a transaction completed in July 2020, structured as all cash.
Engineered Molding Technology LLC (EMT) operates in Fluid Management / Filtration, is based in Whippany / New Jersey, USA. Acquisition of Engineered Molding Technology LLC, a manufacturer of single-use silicone assemblies and components used in the manufacture of biologic drugs. EMT expands Repligen's ProConnex flow-path line and streamlines its ATF supply chain. Effective July 11, 2021, EMT was absorbed into Repligen via short-form merger.
Hunt said 'the acquisition of EMT expands our line of single-use ProConnex flow paths, streamlines our supply chain for ATF, and gives us more flexibility as we scale.'
Vertical integration of single-use silicone flow-path supply. Supply-chain integration for ATF and ProConnex. Repligen Fluid Management / Filtration (absorbed via short-form merger Jul 11, 2021)
The acquisition of EMT expands our line of single-use ProConnex flow paths, streamlines our supply chain for ATF, and gives us more flexibility as we scale.Tony J. Hunt, President and CEO, Repligen
Over the last ten years, EMT has grown to become a key player in the supply of extruded and molded silicone products into the bioprocessing industry.Michael Pandori, co-founder, Engineered Molding Technology
Advisory firms were not disclosed for this transaction.